|
CHM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.22675261247241E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.46549439250521E-14 |
| Normal-vs-Stage2 |
1.372430E-01 |
| Normal-vs-Stage3 |
6.339600E-03 |
| Normal-vs-Stage4 |
5.13940000002044E-07 |
| Stage1-vs-Stage2 |
1.132200E-01 |
| Stage1-vs-Stage3 |
8.382600E-03 |
| Stage1-vs-Stage4 |
7.588600E-01 |
| Stage2-vs-Stage3 |
8.327800E-01 |
| Stage2-vs-Stage4 |
1.222440E-01 |
| Stage3-vs-Stage4 |
1.043160E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.7142953723237E-12 |
| Normal-vs-AfricanAmerican |
3.66380000005329E-06 |
| Normal-vs-Asian |
1.472010E-01 |
| Caucasian-vs-AfricanAmerican |
2.363000E-01 |
| Caucasian-vs-Asian |
5.211400E-01 |
| AfricanAmerican-vs-Asian |
9.340800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62592161956354E-12 |
| Normal-vs-Female |
1.633870E-02 |
| Male-vs-Female |
8.44939999966599E-07 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.4478000000272E-06 |
| Normal-vs-Extreme_Weight |
1.62481139653892E-12 |
| Normal-vs-Obese |
2.27190000001709E-06 |
| Normal-vs-Extreme_Obese |
8.23529999971484E-07 |
| Normal_Weight-vs-Extreme_Weight |
9.324300E-02 |
| Normal_Weight-vs-Obese |
5.877600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.595600E-01 |
| Extreme_Weight-vs-Obese |
9.299100E-03 |
| Extreme_Weight-vs-Extreme_Obese |
5.122600E-01 |
| Obese-vs-Extreme_Obese |
4.401800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.761050E-01 |
| Normal-vs-Age(41-60Yrs) |
4.31130020572823E-10 |
| Normal-vs-Age(61-80Yrs) |
9.76996261670138E-15 |
| Normal-vs-Age(81-100Yrs) |
1.81829999945649E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.190230E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.183500E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.455700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.768200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.102400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.466600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62592161956354E-12 |
| Normal-VS-Type2 PRCC |
6.89990000024565E-07 |
| Normal-VS-KIRP CIMP |
5.657800E-01 |
| Normal-VS-Unclassified PRCC |
7.636400E-04 |
| Type1 PRCC-VS-Type2 PRCC |
1.655860E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.923800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.760500E-02 |
| Type2 PRCC-VS-KIRP CIMP |
1.363250E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.502600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.376800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.97530003465118E-09 |
| Normal-vs-N1 |
1.199840E-02 |
| Normal-vs-N2 |
5.539200E-03 |
| N0-vs-N1 |
9.570000E-02 |
| N0-vs-N2 |
7.056200E-01 |
| N1-vs-N2 |
6.949400E-01 |
|
|
